A cell model for discovering biomarkers and druggable targets for pulmonary fibrosis May 1, 2023 - Nov 30, 2024
All Projects (77)
Quantitative proteomic analysis of pancreatic cyst fluid for early detection of cancer using University of Hull HPC Viper Apr 1, 2022 - Feb 28, 2023
The timely diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenging due to a lack of disease-specific symptoms, resulting in the majority of patients presenting with advanced disease and poor prognosis. Detection of PDAC, ideally at a prem...
Read More about Quantitative proteomic analysis of pancreatic cyst fluid for early detection of cancer using University of Hull HPC Viper.
PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England Feb 1, 2023 - Jan 31, 2024
The grant application is to upgrade the preclinical scanning facilities for nuclear imaging of small animals (mice and rats) at the University of Hull. These facilities are used for research into disease and human health. The main areas that will be...
Read More about PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England.
Study of the lung endothelium in idiopathic pulmonary fibrosis Sep 1, 2020 - Sep 30, 2023
CRN funding - HYPER AID Aug 1, 2022 - Mar 31, 2023
0.5 funding for Dana Schofield for 8 months from 01/08/2022 - 31/03/2023
Support a concerted effort to maximise recruitment to this Diabetes study in Yorkshire and Humber. Although recruitment target has been met, global recruitment (national...
Read More about CRN funding - HYPER AID.
SURPASS EARLY: A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes Sep 1, 2022 - Aug 31, 2027
A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes (SURP...
Read More about SURPASS EARLY: A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes.
ABCD FSL Audit Sep 1, 2022 - Aug 31, 2024
First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing Mar 1, 2023 - Jun 30, 2024
Background: Chronic wounds, delayed healing and surgical site infection affect a significant number of patients and come at great cost to healthcare providers. They substantially decrease quality of life and may lead to repeated hospital admission, s...
Read More about First-in-man clinical trial investigating the effect of hair cycle modulation on wound healing.
ACF 2023-2026 Sep 1, 2023 - Aug 31, 2026
Freeman Fellowship in Diabetes and Endocrinology Apr 1, 2023 - Mar 31, 2030
This is for five PhD studentships to run consecutively over five years in the first instance.
The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery Oct 1, 2023 - Sep 30, 2026
Aims
This study aims to investigate the role of a new dressing (DACC) in preventing wound infection follow vascular surgery. This dressing has a special coating that binds to bacteria irreversibly, allowing them to be removed. The DACC dressin...
Read More about The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post-operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery.
HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD) Nov 1, 2023 - Oct 31, 2024
This project will combine HYMS/Hull’s biomedical and clinical expertise in vascular biology with Emblation’s track record in bringing medical devices to market to validate and commercialise novel patented microwave probes for treatment of peripheral...
Read More about HIKE: A Data Package to Support Clinical Translation of Novel Microwave Probes for Peripheral Arterial Disease (MICRO-PAD).
EARLY DIAPAC: EARLY DIAgnosis of PAncreatic Cancer by combined proteomics and genomics testing of pancreatic cyst fluid. Nov 1, 2023 - May 31, 2024
This is part of a total project cost of £98,508.70.